Hasbani Follows Up The Death Of Farah Kassab And Issues Two Decisions And Two Letters To The General

Hasbani Follows up the Death of Farah Kassab and Issues Two Decisions and Two Letters to the General Prosecution and the Order of Physicians

The Information Office of Deputy Prime Minister Health Minister Ghassan Hasbani issued the following statement:

In the context of following up the death of Farah Kassab after she underwent a cosmetic surgery in a specialized hospital in cosmetic surgeries,

Health Minister Ghassan Hasbani took the following actions:

The issuance of a decision on the prevention of surgical operations that require a general anesthetic in day hospitals or other cosmetic surgery clinics.
The issuance of a decision on the prevention of surgical operations that require a general anesthetic in Dr. Nader Saab hospital specialized in cosmetic surgery.
The issuance of a letter to the Public Prosecutor to investigate into the death of Farah Kassab.
The issuance of a letter to the Lebanese Order of Physicians in Beirut to conduct necessary investigations into the death of Farah Kassab, and give the Order a period of two weeks to clarify some technical medical points and answer questions asked by Health Minister concerning the death of the said woman.

These steps came to complete the immediate oral decision of Health Minister Ghassan Hasbani to cease operations in the said clinic after the woman's death, and the written decision issued Friday 2 June 2017 which stipulates the following:

Surgeries that may cause complications that require intensive care like liposuction and other surgeries shall not performed in places other than specialized hospitals which include an intensive care division that holds a license form Health Ministry in accordance with due process.
The doctor should explain to the patient the risks of the surgery, including the plastic surgery, and ask the patient to sign the Patient Right Form and the informed consent.

...

194

ATC	Name	B/G	Ingredients	Dosage	Form	Price
N02BE01	PARA-DENK 125 SUPPOS.	G	Paracetamol - 125mg	125mg	Suppository	190,826 L.L
N04BD02	RASAGILINE BIOGARAN	G	Rasagiline - 1mg	1mg	Tablet	5,214,109 L.L
N06AX16	DEPREVIX HELLAS	G	Venlafaxine - 150mg	150mg	Capsule, prolonged release	968,910 L.L
R06AX28	RUPATADINE BIOGARAN	G	Rupatadine - 10mg	10mg	Tablet	341,336 L.L
A04AD12	APREPITANT BIOGARAN	G	Aprepitant - 80mg	80mg	Capsule	1,986,199 L.L
B01AC24	KLOTEGO	G	Ticagrelor - 90mg	90mg	Tablet, film coated	2,598,096 L.L
B05BB02	SOLUFLEX DEXTROSE 5% SODIUM CHLORIDE 0.45% INJECTION, USP	G	Sodium chloride - 0.45%, Glucose - 5%		Injectable solution	211,449 L.L
C01CA03	? NORADRENALINE	G	Norepinephrine tartrate - 8mg/4ml	8mg/4ml	Injectable solution	330,201 L.L
C09DX03	OLMENOR TRIPLE	G	Olmesartan medoxomil - 40mg, Amlodipine (besylate) - 10mg, Hydrochlorothiazide - 12.5mg		Tablet, film coated	1,067,011 L.L
G03DA04	PROGEST	G	Progesterone micronised - 100mg	100mg	Capsule, soft gelatin	368,213 L.L
J02AC02	FONGINOX	G	Itraconazole - 100mg	100mg	Capsule	174,060 L.L
L01BC06	CAPECITABINE PHARMINICIO	G	Capecitabine - 500mg	500mg	Tablet, film coated	8,869,508 L.L
M01AX05	DONA	G	Glucosamine hemisulfate - 1500mg	1500mg	Powder for solution	1,615,299 L.L
N02BE01	PARA-DENK 125 SUPPOS.	G	Paracetamol - 125mg	125mg	Suppository	190,826 L.L
N04BD02	RAZYLECT 1	G	Rasagiline mesylate - 1mg	1mg	Tablet	3,532,514 L.L
N06AX16	DEPREVIX HELLAS	G	Venlafaxine - 150mg	150mg	Capsule, prolonged release	968,910 L.L
R03AK07	BUFOMIX EASYHALER	G	Formoterol fumarate dihydrate - 4.5mcg/inhalation, Budesonide - 160mcg/inhalation		Metered dose inhaler	2,365,163 L.L

...

194